AI stethoscope aims to cut unnecessary antibiotics in kids
NCT ID NCT07631377
First seen Jun 19, 2026 · Last updated Jun 19, 2026
Summary
This study tests whether an AI-enhanced digital stethoscope can improve pneumonia diagnosis in children aged 2 to 59 months who have cough or breathing trouble. About 350 children will be randomly assigned to standard care or care plus the AI stethoscope. An independent panel of doctors will determine if pneumonia is actually present. The goal is to see if the AI tool helps target antibiotics more accurately, reducing unnecessary use and fighting antibiotic resistance.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMONIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
StethoMe AI-enabled digital stethoscope
What this could lead to
If successful, this could lead to more accurate pneumonia diagnosis in children, reducing unnecessary antibiotic use and helping fight antibiotic resistance.
What could go wrong
This is a single-site study in South Africa, and results may not apply to other settings. The AI results are not used in patient care, so direct benefit to participants is limited.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.